loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Acelarin, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Acelarin

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass

    Inke S.A: APIs manufacturing plant.

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    2D Structure
    1. Also known as: 840506-29-8, Nuc-1031, Fosgemcitabine palabenamide, p(rs)-, Xcl1k2t28k, Cpf-31, Benzyl (2s)-2-[[[(2r,3r,5r)-5-(4-amino-2-oxopyrimidin-1-yl)-4,4-difluoro-3-hydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate
    Molecular Formula
    C25H27F2N4O8P
    Molecular Weight
    580.5  g/mol
    InChI Key
    NHTKGYOMICWFQZ-KKQYNPQSSA-N
    FDA UNII
    XCL1K2T28K
    NUC-1031 is under investigation in clinical trial NCT03610100 (Acelarin First Line Randomised Pancreatic Study).
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    benzyl (2S)-2-[[[(2R,3R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4,4-difluoro-3-hydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate
    2.1.2 InChI
    InChI=1S/C25H27F2N4O8P/c1-16(22(33)36-14-17-8-4-2-5-9-17)30-40(35,39-18-10-6-3-7-11-18)37-15-19-21(32)25(26,27)23(38-19)31-13-12-20(28)29-24(31)34/h2-13,16,19,21,23,32H,14-15H2,1H3,(H,30,35)(H2,28,29,34)/t16-,19+,21+,23+,40?/m0/s1
    2.1.3 InChI Key
    NHTKGYOMICWFQZ-KKQYNPQSSA-N
    2.1.4 Canonical SMILES
    CC(C(=O)OCC1=CC=CC=C1)NP(=O)(OCC2C(C(C(O2)N3C=CC(=NC3=O)N)(F)F)O)OC4=CC=CC=C4
    2.1.5 Isomeric SMILES
    C[C@@H](C(=O)OCC1=CC=CC=C1)NP(=O)(OC[C@@H]2[C@H](C([C@@H](O2)N3C=CC(=NC3=O)N)(F)F)O)OC4=CC=CC=C4
    2.2 Other Identifiers
    2.2.1 UNII
    XCL1K2T28K
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Nuc-1031

    2.3.2 Depositor-Supplied Synonyms

    1. 840506-29-8

    2. Nuc-1031

    3. Fosgemcitabine Palabenamide, P(rs)-

    4. Xcl1k2t28k

    5. Cpf-31

    6. Benzyl (2s)-2-[[[(2r,3r,5r)-5-(4-amino-2-oxopyrimidin-1-yl)-4,4-difluoro-3-hydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate

    7. L-alanine, N-(2'-deoxy-2',2'-difluoro-p-phenyl-5'-cytidylyl)-, Phenylmethyl Ester

    8. Benzyl (2s)-2-((((2r,3r,5r)-5-(4-amino-2-oxo-pyrimidin-1-yl)-4,4-difluoro-3-hydroxy-tetrahydrofuran-2-yl)methoxy-phenoxy-phosphoryl)amino)propanoate

    9. Gemictabine Protide

    10. Acelarinnuc1031

    11. Unii-xcl1k2t28k

    12. Acelarin (nuc-1031)

    13. Chembl3126004

    14. Schembl16769342

    15. Amy38903

    16. Ex-a4416

    17. S9649

    18. Cs-6147

    19. Db15057

    20. Hy-100885

    21. (2s)-benzyl 2-(((((2r,3r,5r)-5-(4-amino-2-oxopyrimidin-1(2h)-yl)-4,4-difluoro-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate

    22. Benzyl ((((2r,3r,5r)-5-(4-amino-2-oxopyrimidin-1(2h)-yl)-4,4-difluoro-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-l-alaninate

    2.4 Create Date
    2006-10-26
    3 Chemical and Physical Properties
    Molecular Weight 580.5 g/mol
    Molecular Formula C25H27F2N4O8P
    XLogP31.4
    Hydrogen Bond Donor Count3
    Hydrogen Bond Acceptor Count11
    Rotatable Bond Count12
    Exact Mass580.15345715 g/mol
    Monoisotopic Mass580.15345715 g/mol
    Topological Polar Surface Area162 Ų
    Heavy Atom Count40
    Formal Charge0
    Complexity1020
    Isotope Atom Count0
    Defined Atom Stereocenter Count4
    Undefined Atom Stereocenter Count1
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    Post Enquiry
    POST ENQUIRY